December 2nd – A volunteer in India who participated in the coronavirus vaccine trial said that after vaccination, he developed serious neurological diseases and even amnesia.
The volunteer tested a vaccine in Chennai, a “Covishield” developed by the British pharmaceutical company AstraZeneca and Oxford University, according to India Today. The man said he was vaccinated on October 1, and a few days later he started to have a headache and can’t remember what happened over the next 10 days.”
I don’t remember anything, I don’t know anyone, and I’ve been in a state of insanity all day. Later that day, the doctor came to see me and let an ambulance take me to the hospital. I can’t remember what happened in the next 10 days.
I was sent to the intensive care unit, as I heard from my family. Ten days later, I was sent home. “He feels much better now,” the man said.” I’m much better now and have nearly recovered 100%. But that can’t change everything I’ve been going through.”
The volunteer’s family asked the local government to stop testing the vaccine and investigate the factors that caused his experience.” When I had an adverse reaction, they were still recruiting volunteers and vaccinating them.
My wife asked to stop the trial, but they didn’t stop,” he said, the government should investigate adverse events after vaccination and assess whether the adverse reactions were caused by the vaccine or other factors. The volunteer has sued the Indian Serum Institute for Rs 500 million.
On the 1st local time, the Indian Serological Research Institute issued a statement denying the allegations and saying that the vaccine is safe. Meanwhile, the Indian Serum Institute said that it had filed a defamation lawsuit of Rs 100 million against the volunteer.
The Indian Serum Institute called the allegations “malicious and wrong”: “The indictment has been sent to this volunteer to maintain the reputation of the company.”
In September this year, the Indian Serological Research Institute briefly suspended the clinical trial of Covishield after patients receiving AstraZeneca injections developed adverse symptoms. India has been criticized for its lack of transparency in its coronavirus vaccine trials.
The Indian Serum Institute did not use the same Phase 3 testing scheme as AstraZeneca, and also refused to make its guidelines public, according to Science. Overseas Network Li Fang)
